miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1

Tumor Biology

Volumn 37, Issue 5, 2016, Pages 6761-6768

  Chen, Hanchun ^a   Lu, Qiong ^b   Fei, Xifeng ^a   Shen, Likui ^a   Jiang, Dongyi ^a   Dai, Dongwei ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glioblastoma; miR 22; SIRT1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; MICRORNA 22; SIRTUIN 1; 3' UNTRANSLATED REGION; MESSENGER RNA; MICRORNA; MIRN22 MICRORNA, HUMAN; TRANSCRIPTOME;

3' UNTRANSLATED REGION; ARTICLE; ASTROCYTE; CANCER GROWTH; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SIRT1 GENE; UPREGULATION; CELL MOTION; CHEMISTRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; MORTALITY; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS; RNA INTERFERENCE; RNA, MESSENGER; SIRTUIN 1; TRANSCRIPTOME;

EID: 84949554343     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4575-8     Document Type: Article

References (25)

1. Jemal A, Siegel R, Xu J. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
2. Liao A, Shi R, Jiang Y, Tian S, Li P, Song F, et al. SDF-1/CXCR4 axis regulates cell cycle progression and epithelial-mesenchymal transition via up-regulation of survivin in glioblastoma. Mol Neurobiol. 2014 Nov 25.
3. Lv Q, Zhang J, Yi Y, Huang Y, Wang Y, Wang Y, et al. Proliferating cell nuclear antigen has an association with prognosis and risks factors of cancer patients: a systematic review. Mol Neurobiol. 2015.
4. Lv B, Yang X, Lv S, Wang L, Fan K, Shi R, et al. CXCR4 signaling induced epithelial-mesenchymal transition by PI3K/AKT and ERK pathways in glioblastoma. Mol Neurobiol. 2015;52(3):1263–8.
5. Altieri R, Fontanella M, Agnoletti A, Panciani PP, Spena G, Crobeddu E, et al. Role of nitric oxide in glioblastoma therapy: another step to resolve the terrible puzzle? Transl Med UniSa. 2014;12:54–9.
6. De Paepe A, Vandeneede N, Strens D, Specenier P. The economics of the treatment and follow-up of patients with glioblastoma. Value Health. 2015;18(7):A448.
7. Kagiya T. MicroRNAs and osteolytic bone metastasis: the roles of microRNAs in tumor-induced osteoclast differentiation. J Clin Med. 2015;4(9):1741–52.
8. Sanei M, Chen X. Mechanisms of microRNA turnover. Curr Opin Plant Biol. 2015;27:199–206.
9. Luna-Aguirre CM, de la Luz M-FM, Mar-Aguilar F, Garza-Veloz I, Treviño-Alvarado V, Rojas-Martinez A, et al. Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia. Cancer Biomark. 2015;15(3):299–310.
10. Sampson VB, Yoo S, Kumar A, Vetter NS, Kolb EA. MicroRNAs and potential targets in osteosarcoma: review. Front Pediatr. 2015;3:69.
11. Kanda M, Kodera Y. Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol. 2015;21(34):9838–52.
12. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433(7027):769–73.
13. Lu W, You R, Yuan X, Yang T, Samuel EL, Marcano DC, et al. The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote TH17 cell-dependent emphysema. Nat Immunol. 2015;16(11):1185–94.
14. Yang Q, Jiang W, Zhuang C, Geng Z, Hou C, Huang D, et al. MicroRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer. Oncol Rep. 2015;34(4):1771–8.
15. Zhou Y, Zhou Z, Zhang W, Hu X, Wei H, Peng J, et al. SIRT1 inhibits adipogenesis and promotes myogenic differentiation in C3H10T1/2 pluripotent cells by regulating Wnt signaling. Cell Biosci. 2015;5:61.
16. Maiese K. MicroRNAs and SIRT1: a strategy for stem cell renewal and clinical development? J Transl Sci. 2015;1(3):55–7.
17. Shuang T, Wang M, Zhou Y, Shi C. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC). Med Oncol. 2015;32(12):260.
18. Xiong J, Yu D, Wei N, Fu H, Cai T, Huang Y, et al. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J. 2010;277:1684–94.
19. García I, Vizoso F, Andicoechea A, Fernandez P, Suarez C, García-Muñz JL, et al. C-erbB-2 oncoprotein content in gastric cancer and in adjacent mucosa. Int J Biol Markers. 2000;15(3):231–4.
20. Dan L, Jian D, Na L, Xiaozhong W. Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901. Onco Targets Ther. 2012;5:271–7.
21. Chen W, Zhong X, Wei Y, Liu Y, Yi Q, Zhang G, et al. TGF-β regulates survivin to affect cell cycle and the expression of EGFR and MMP9 in glioblastoma. Mol Neurobiol. 2015.
22. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52–67.
23. Yang X, Lv S, Liu Y, Li D, Shi R, Tang Z, et al. The clinical utility of matrix metalloproteinase 9 in evaluating pathological grade and prognosis of glioma patients: a meta-analysis. Mol Neurobiol. 2015;52(1):38–44.
24. Kumar B, Koul S, Petersen J, Khandrika L, Hwa JS, Meacham RB, et al. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res. 2010;70(2):832–41.
25. Yao C, Li P, Song H, Song F, Qu Y, Ma X, et al. CXCL12/CXCR4 axis upregulates twist to induce EMT in human glioblastoma. Mol Neurobiol. 2015.